{"database": "lobbying", "table": "lobbying_activities", "rows": [[658767, "99dde7bd-20a9-4688-86d3-0c13602c8746", "3T", "LENT SCRIVNER & ROTH LLC", 22611, "AMGEN INC", 2008, "third_quarter", "HCR", "Biosimilars Legislation\nHR 1038 - Access to Life Savings Medicine Act\nHR 1956 - Patient Protection and Innovative Biologic Medicines Act of 2007\nFDA Drug Safety Oversight", "HOUSE OF REPRESENTATIVES,SENATE", 20000, null, 0, 1, "2008-08-08T08:59:46-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["658767"], "units": {}, "query_ms": 0.3509300295263529, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}